- The trend backdrop is active with a 12-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
LLYC
VIE
Week ended 11 Sep 2026
Weekly Investor Report
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
Latest close
964.50 EUR
-1.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 4.4% above the Trend Line and sits at 73.0% of its 52-week range. The latest completed week returned -1.9%, after a -5.7% four-week move. The latest news-sentiment score is 57/100.
Setup score
54
out of 100
Latest Close
964.50 EUR
11 Sep 2026
1W Return
-1.9%
latest completed week
4W Return
-5.7%
short-term follow-through
12W Return
0.3%
quarterly tape
Trend Breadth
61.5%
32 of 52 weeks active
Volume Ratio
2.2x
vs 13-week average
- 5 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.9%
Latest completed week; four-week move -5.7%.
Indicator stack
75/47
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 57.82%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
57/100
95 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 4.4% above the Trend Line and sits at 73.0% of its 52-week range. The latest completed week returned -1.9%, after a -5.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8112-week average 0.75
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.81Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers
No recent accumulation markers. 5 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.7% over four weeks, 0.3% over 12 weeks, and 51.4% over one year. The current trend has remained active for 12 consecutive weeks.
Performance by holding period
Active trend streak12 weeks
Active weeks in one year32
Trend breadth61.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.16Latest activity-pressure read.
Pressure change-72.5%Four-week change in activity pressure.
Leadership-10.06Latest relative-leadership reading.
RS change-483.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 95 relevant articles.
25 positive · 59 neutral · 11 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-11.9%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
20 Mar
17 Apr
15 May
12 Jun
10 Jul
7 Aug
11 Sep
Weeks higher14 of 2612 weeks finished lower.
Best week+8.5%Week of 26 Jun.
Worst week-7.9%Week of 20 Mar.
Latest week-1.9%Week of 11 Sep.
Shape of recent returns
Strong gains7
Modest gains7
Flat weeks0
Modest losses9
Sharp losses3
Recent vol4.1%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank69 / 100
Group average-1.2%
Trend breadth65.0%
Trend65.0%active weekly trend signals
MD67.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryAT Drug Manufacturers - General
4-week rank14 / 17
Group average-1.0%
Trend breadth88.2%
Trend88.2%active weekly trend signals
MD88.2%positive activity pressure
RS11.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape57/100
Trend, activity pressure, participation, and risk combine to a 57/100 tape read.
Indicator analysis72/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 7/12.
Activity pressure 0.81; 5 reversal markers Next-Week ExpectancyPositive 57.82%Next-week expectancy is positive with a 57.82% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 95 relevant articles.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 11 Sep 2026 | 964.50 EUR | -1.9% | 923.64 EUR | 756.36 EUR | 0.16 | -10.06 | 216 | On |
| 4 Sep 2026 | 983.30 EUR | -2.7% | 920.86 EUR | 753.61 EUR | 0.44 | -7.91 | 277 | On |
| 28 Aug 2026 | 1,010.80 EUR | -7.0% | 917.62 EUR | 750.72 EUR | 0.59 | -4.23 | 165 | On |
| 21 Aug 2026 | 1,086.40 EUR | 6.2% | 912.85 EUR | 747.48 EUR | 0.68 | 5.52 | 193 | On |
| 14 Aug 2026 | 1,022.60 EUR | 0.5% | 907.08 EUR | 743.72 EUR | 0.59 | -1.72 | 107 | On |
| 7 Aug 2026 | 1,017.94 EUR | 2.6% | 902.89 EUR | 740.30 EUR | 0.59 | -0.61 | 30 | On |
| 31 Jul 2026 | 991.98 EUR | -5.6% | 899.75 EUR | 736.80 EUR | 0.64 | 0.27 | 46 | On |
| 24 Jul 2026 | 1,050.68 EUR | 1.4% | 896.78 EUR | 732.99 EUR | 0.74 | 6.34 | 36 | On |
| 17 Jul 2026 | 1,036.11 EUR | 0.0% | 892.06 EUR | 728.85 EUR | 0.82 | 6.55 | 20 | On |
| 10 Jul 2026 | 1,035.91 EUR | -1.8% | 887.68 EUR | 724.82 EUR | 0.77 | 4.77 | 37 | On |
| 3 Jul 2026 | 1,054.80 EUR | 1.0% | 881.96 EUR | 720.67 EUR | 0.77 | 5.52 | 53 | On |
| 26 Jun 2026 | 1,044.00 EUR | 8.5% | 875.73 EUR | 716.50 EUR | 0.75 | 7.20 | 112 | On |
| 19 Jun 2026 | 961.90 EUR | -2.8% | 871.70 EUR | 712.48 EUR | 0.71 | -2.91 | 0 | Off |
| 12 Jun 2026 | 989.20 EUR | -1.7% | 870.00 EUR | 708.95 EUR | 0.70 | 4.08 | 45 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.